Summary
The product Deca 200 mg/ml, manufactured by PrimePharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number PP1768, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Nandrolone Decanoate, with a concentration of 205.94 mg/ml, slightly exceeding the labeled claim of 200 mg/ml by 2.97%.
The testing process began on 2 May 2023, with the sample received on 11 May 2023, and analysis completed on 15 May 2023. While the results confirm accurate dosing, scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Deca 200 mg/ml
- Active Ingredient: Nandrolone Decanoate
- Batch Number: PP1768
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29404
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 205.94 mg/ml
- Accuracy: 102.97% (2.97% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/29404_Q5QEZBP2YY6H
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller Opitropin.EU. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Deca 200 mg/ml is slightly overdosed, with a measured concentration of 205.94 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
